Oraverse (Septodont, Inc.)


Welcome to the PulseAid listing for the Oraverse drug offered from Septodont, Inc.. This Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Septodont, Inc.
NON-PROPRIETARY NAME: Phentolamine Mesylate
SUBSTANCE NAME: PHENTOLAMINE MESYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
ROUTE: SUBMUCOSAL
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2011-06-01
END MARKETING DATE: 0000-00-00


Oraverse HUMAN PRESCRIPTION DRUG Details:

Item DescriptionOraverse from Septodont, Inc.
LABELER NAME: Septodont, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.235(mg/mL)
START MARKETING DATE: 2011-06-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0362-0101_fbc184a3-a9b7-447d-b100-fddcd2b07bf4
PRODUCT NDC: 0362-0101
APPLICATION NUMBER: NDA022159

Other PHENTOLAMINE MESYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Precision Dose Inc.PHENTOLAMINE MESYLATE
Septodont, Inc.Oraverse
West-Ward Pharmaceuticals CorpPhentolamine Mesylate